Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers Guidance

Gilead Sciences Announces Fourth Quarter and Full Year 2017 Financial Results

February 6, 2018 4:01 PM EST

- Fourth Quarter Product Sales of $5.8 billion -

- Full Year 2017 Product Sales of $25.7 billion -

- Full Year 2017 Diluted EPS of $3.51 per share -

- Full Year 2017 Non-GAAP Diluted EPS of $8.84 per share -

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2017. Total revenues for the fourth quarter of 2017 were $5.9 billion compared to $7.3 billion... More